Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica

Neurobiology of Disease

Volumn 37, Issue 2, 2010, Pages 349-355

  Kim, Ho Jin ^a   Park, Hyun Young ^b   Kim, Eunkyung ^b   Lee, Kwang Soo ^b   Kim, Kwang Kuk ^c   Choi, Byung Ok ^d   Kim, Seung Min ^e   Bae, Joon Seol ^g   Lee, Soo Ok ^f   Chun, Ji Yong ^g   Park, Tae Joon ^g   Cheong, Hyun Sub ^f   Jo, Inho ^b   Shin, Hyoung Doo ^f,g  

^a National Cancer Center   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c University of Ulsan   (South Korea)

^d Ewha Womans University   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f SNP Genetics Inc   (South Korea)

^g Sogang University   (South Korea)

Author keywords

CYP7A1; Genome wide association study; Korean population; Neuromyelitis optica; Promoter variant; Single nucleotide polymorphism

Indexed keywords

CHOLESTEROL 7ALPHA MONOOXYGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; GENE DOSAGE; GENOME; HLA TYPING; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; RECURRENT DISEASE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DOSAGE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; OPTIC NERVE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SPINAL CORD;

EID: 73049089684     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.10.013     Document Type: Article

References (33)

1. Argyriou A.A., and Makris N. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system. Acta Neurol. Scand. 118 4 (2008) 209-217
2. Cooper A.D., Chen J., Botelho-Yetkinler M.J., Cao Y., Taniguchi T., and Levy-Wilson B. Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7alpha-hydroxylase gene. J. Biol. Chem. 272 6 (1997) 3444-3452
3. Das A., and Puvanendran K. A retrospective review of patients with clinically definite multiple sclerosis. Ann. Acad. Med. Singapore 27 2 (1998) 204-209
4. de Bakker P.I., McVean G., Sabeti P.C., Miretti M.M., Green T., Marchini J., Ke X., Monsuur A.J., Whittaker P., Delgado M., Morrison J., Richardson A., Walsh E.C., Gao X., Galver L., Hart J., Hafler D.A., Pericak-Vance M., Todd J.A., Daly M.J., Trowsdale J., Wijmenga C., Vyse T.J., Beck S., Murray S.S., Carrington M., Gregory S., Deloukas P., and Rioux J.D. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38 10 (2006) 1166-1172
5. Fukazawa T., Yamasaki K., Ito H., Kikuchi S., Minohara M., Horiuchi I., Tsukishima E., Sasaki H., Hamada T., Nishimura Y., Tashiro K., and Kira J. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 55 3 (2000) 199-205
6. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., and Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357 9 (2007) 851-862
7. Hagiwara T., Kono S., Yin G., Toyomura K., Nagano J., Mizoue T., Mibu R., Tanaka M., Kakeji Y., Maehara Y., Okamura T., Ikejiri K., Futami K., Yasunami Y., Maekawa T., Takenaka K., Ichimiya H., and Imaizumi N. Genetic polymorphism in cytochrome P450 7A1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Res. 65 7 (2005) 2979-2982
8. Hedrick P.W. Gametic disequilibrium measures: proceed with caution. Genetics 117 2 (1987) 331-341
9. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6 2 (2005) 95-108
10. Hofman M.K., Princen H.M., Zwinderman A.H., and Jukema J.W. Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events. Clin. Sci. (Lond.) 108 6 (2005) 539-545
11. Hudson G., Mowbray C., Elson J.L., Jacob A., Boggild M., Torroni A., and Chinnery P.F. Does mitochondrial DNA predispose to neuromyelitis optica (Devic's disease). Brain 131 Pt 4 (2008) e93
12. Jiang Z.Y., Han T.Q., Suo G.J., Feng D.X., Chen S., Cai X.X., Jiang Z.H., Shang J., Zhang Y., Jiang Y., and Zhang S.D. Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J. Gastroenterol. 10 10 (2004) 1508-1512
13. Juzyszyn Z., Kurzawski M., Lener A., Modrzejewski A., Pawlik A., and Drozdzik M. Cholesterol 7alpha-hydrolase (CYP7A1) c.-278A > C promoter polymorphism in gallstone disease patients. Genet. Test 12 1 (2008) 97-100
14. Kalman B., and Mandler R.N. Studies of mitochondrial DNA in Devic's disease revealed no pathogenic mutations, but polymorphisms also found in association with multiple sclerosis. Ann. Neurol. 51 5 (2002) 661-662
15. Kenealy S.J., Pericak-Vance M.A., and Haines J.L. The genetic epidemiology of multiple sclerosis. J. Neuroimmunol. 143 1-2 (2003) 7-12
16. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2 2 (2003) 117-127
17. Lee S.K., Rho J.K., Lee S.B., and Myung H.J. Multiple sclerosis in Korea-its clinical features and estimated prevalence rate. Kor. J. Neurobiol. 7 1 (1989) 218-228
18. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 6 (2000) 707-717
19. Menashe I., Rosenberg P.S., and Chen B.E. PGA: power calculator for case-control genetic association analyses. BMC Genet. 9 (2008) 36
20. Molowa D.T., Chen W.S., Cimis G.M., and Tan C.P. Transcriptional regulation of the human cholesterol 7 alpha-hydroxylase gene. Biochemistry 31 9 (1992) 2539-2544
21. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74 4 (2004) 765-769
22. Qiao Y., Liu R., Bai H., Liu Y., Li X., Tang C.W., and Liu B.W. Association between cholesterol 7alpha-hydroxylase -204A/C gene polymorphism and endogenous hypertriglyceridemia in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24 4 (2007) 432-436
23. Risch N.J. Searching for genetic determinants in the new millennium. Nature 405 6788 (2000) 847-856
24. Russell D.W., and Setchell K.D. Bile acid biosynthesis. Biochemistry 31 20 (1992) 4737-4749
25. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70 2 (2002) 425-434
26. Sospedra M., and Martin R. Antigen-specific therapies in multiple sclerosis. Int. Rev. Immunol. 24 5-6 (2005) 393-413
27. Srivastava A., Pandey S.N., Choudhuri G., and Mittal B. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. Mol. Genet. Metab. 94 1 (2008) 83-89
28. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 4 (2001) 978-989
29. Tabata S., Yin G., Ogawa S., Yamaguchi K., Mineshita M., and Kono S. Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci. 97 5 (2006) 406-410
30. The International HapMap Consortium. The International HapMap Project. Nature 426 6968 (2003) 789-796
31. Weinshenker B.G., Wingerchuk D.M., Nakashima I., Fujihara K., and Lennon V.A. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol. 5 2 (2006) 110-111
32. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., and Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53 5 (1999) 1107-1114
33. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., and Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 10 (2006) 1485-1489